Chris Eng - Profile and Investment Details

Investor Profile

Chris Eng is a Venture Capital, Private Equity Firm based in Washington, District of Columbia, United States with a diverse investment portfolio that includes companies such as Anaplan, Bridgit, UiPath, Kit Check, Avitide, MuleSoft, Agilis Biotherapeutics, Farcast, Funding CircleBYJU’S, HUNGRY, Nanoview Biosciences, Freenome, Genometry, DoorDash, Candel, Karuna Therapeutics, Kidaptive, AppDynamics, Upgrade, Modernizing Medicine, ArcherDX, Coagulo Medical Technologies, DataRobot, SeLux Diagnostics, BigBasket, Vesper, Day Zero Diagnostics, Complete Genomics, Blackbuck, Earli, Papercup, Zaarly, Allvision, Thrive Earlier Detection, DocuSign, Paydiant, DiCE Molecules, Taysha Gene Therapies, Stipple, Uhnder, Slack, NepFin, Quad Technologies, Health Catalyst, WireWheel.io, Qvella Corporation, Lending Club, Scopely, Betable, Brightflag, Totient, Firefly BioWorks, Teckro, . Over time, Chris Eng has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Chris Eng is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Autonomous Vehicles, E-commerce, Cybersecurity, Disruptive Innovation, Digital Infrastructure, Enterprise Software, Investment Management, Digital Media, Intelligent Systems, Apps, Healthcare Innovation, Strategic Partnerships, Life Science, Emerging Markets, Automotive, Artificial Intelligence (AI), Tech, Analytics, Cloud Computing, Internet of Things (IoT), Finance, Software, Biotechnology, Video, Market Research, Legal Tech, Innovation, Disruptive technology, Digital Transformation, Consumer Software, Hardware, Marketing, Social Impact, Regulatory Compliance, Medical, SaaS, Information Technology, B2B, Media and Entertainment, Machine Learning, Risk Management, Business Intelligence may find it worthwhile to explore potential connections with Chris Eng, as their portfolio suggests a familiarity and interest in this area.

Understanding Chris Eng’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.